nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—UGT2B7—Epirubicin—uterine cancer	0.221	0.288	CbGbCtD
Oxazepam—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.135	0.176	CbGbCtD
Oxazepam—CYP3A7—Progesterone—uterine cancer	0.135	0.176	CbGbCtD
Oxazepam—CYP3A5—Progesterone—uterine cancer	0.102	0.132	CbGbCtD
Oxazepam—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0598	0.0778	CbGbCtD
Oxazepam—CYP3A5—Etoposide—uterine cancer	0.0454	0.0591	CbGbCtD
Oxazepam—CYP3A4—Progesterone—uterine cancer	0.0396	0.0515	CbGbCtD
Oxazepam—CYP3A4—Etoposide—uterine cancer	0.0177	0.0231	CbGbCtD
Oxazepam—CYP3A4—Doxorubicin—uterine cancer	0.0121	0.0157	CbGbCtD
Oxazepam—Slurred speech—Progesterone—uterine cancer	0.0104	0.0495	CcSEcCtD
Oxazepam—Menstruation irregular—Progesterone—uterine cancer	0.00843	0.04	CcSEcCtD
Oxazepam—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.00764	0.0362	CcSEcCtD
Oxazepam—Stupor—Progesterone—uterine cancer	0.00625	0.0296	CcSEcCtD
Oxazepam—Memory impairment—Progesterone—uterine cancer	0.00595	0.0282	CcSEcCtD
Oxazepam—Aggression—Progesterone—uterine cancer	0.00531	0.0252	CcSEcCtD
Oxazepam—Blood disorder—Medroxyprogesterone Acetate—uterine cancer	0.00506	0.024	CcSEcCtD
Oxazepam—Dysarthria—Progesterone—uterine cancer	0.00493	0.0234	CcSEcCtD
Oxazepam—Depressed level of consciousness—Progesterone—uterine cancer	0.00451	0.0214	CcSEcCtD
Oxazepam—Dysarthria—Medroxyprogesterone Acetate—uterine cancer	0.00447	0.0212	CcSEcCtD
Oxazepam—Hepatic function abnormal—Progesterone—uterine cancer	0.00388	0.0184	CcSEcCtD
Oxazepam—Disorientation—Progesterone—uterine cancer	0.00379	0.018	CcSEcCtD
Oxazepam—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00363	0.0172	CcSEcCtD
Oxazepam—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00351	0.0167	CcSEcCtD
Oxazepam—Diplopia—Progesterone—uterine cancer	0.00339	0.0161	CcSEcCtD
Oxazepam—Amnesia—Medroxyprogesterone Acetate—uterine cancer	0.00327	0.0155	CcSEcCtD
Oxazepam—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00289	0.0137	CcSEcCtD
Oxazepam—Drowsiness—Progesterone—uterine cancer	0.00261	0.0124	CcSEcCtD
Oxazepam—Jaundice—Progesterone—uterine cancer	0.00254	0.0121	CcSEcCtD
Oxazepam—Body temperature increased—Carboplatin—uterine cancer	0.00251	0.0119	CcSEcCtD
Oxazepam—Lethargy—Dactinomycin—uterine cancer	0.00244	0.0116	CcSEcCtD
Oxazepam—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00237	0.0112	CcSEcCtD
Oxazepam—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00231	0.0109	CcSEcCtD
Oxazepam—Vision blurred—Progesterone—uterine cancer	0.00192	0.00912	CcSEcCtD
Oxazepam—Tremor—Progesterone—uterine cancer	0.00191	0.00907	CcSEcCtD
Oxazepam—Vertigo—Progesterone—uterine cancer	0.00183	0.00869	CcSEcCtD
Oxazepam—Syncope—Progesterone—uterine cancer	0.00183	0.00868	CcSEcCtD
Oxazepam—Loss of consciousness—Progesterone—uterine cancer	0.00179	0.0085	CcSEcCtD
Oxazepam—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00821	CcSEcCtD
Oxazepam—Agranulocytosis—Dactinomycin—uterine cancer	0.00172	0.00817	CcSEcCtD
Oxazepam—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00806	CcSEcCtD
Oxazepam—Oedema—Progesterone—uterine cancer	0.00167	0.0079	CcSEcCtD
Oxazepam—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00788	CcSEcCtD
Oxazepam—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00786	CcSEcCtD
Oxazepam—Shock—Progesterone—uterine cancer	0.00164	0.00777	CcSEcCtD
Oxazepam—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00771	CcSEcCtD
Oxazepam—Blood disorder—Epirubicin—uterine cancer	0.0016	0.0076	CcSEcCtD
Oxazepam—Hypotension—Progesterone—uterine cancer	0.00156	0.00738	CcSEcCtD
Oxazepam—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00716	CcSEcCtD
Oxazepam—Paraesthesia—Progesterone—uterine cancer	0.0015	0.00709	CcSEcCtD
Oxazepam—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00704	CcSEcCtD
Oxazepam—Blood disorder—Doxorubicin—uterine cancer	0.00148	0.00703	CcSEcCtD
Oxazepam—Somnolence—Progesterone—uterine cancer	0.00148	0.00702	CcSEcCtD
Oxazepam—Dysarthria—Epirubicin—uterine cancer	0.00141	0.00671	CcSEcCtD
Oxazepam—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00669	CcSEcCtD
Oxazepam—Gastrointestinal pain—Progesterone—uterine cancer	0.00136	0.00646	CcSEcCtD
Oxazepam—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00643	CcSEcCtD
Oxazepam—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00636	CcSEcCtD
Oxazepam—Abdominal pain—Progesterone—uterine cancer	0.00132	0.00624	CcSEcCtD
Oxazepam—Body temperature increased—Progesterone—uterine cancer	0.00132	0.00624	CcSEcCtD
Oxazepam—Dysarthria—Doxorubicin—uterine cancer	0.00131	0.00621	CcSEcCtD
Oxazepam—Jaundice—Etoposide—uterine cancer	0.0013	0.00617	CcSEcCtD
Oxazepam—UGT2B15—female reproductive system—uterine cancer	0.00129	0.0695	CbGeAlD
Oxazepam—Leukopenia—Dactinomycin—uterine cancer	0.00129	0.00612	CcSEcCtD
Oxazepam—Agranulocytosis—Etoposide—uterine cancer	0.00125	0.00591	CcSEcCtD
Oxazepam—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00585	CcSEcCtD
Oxazepam—Hypersensitivity—Progesterone—uterine cancer	0.00123	0.00582	CcSEcCtD
Oxazepam—UGT1A9—renal system—uterine cancer	0.00122	0.0658	CbGeAlD
Oxazepam—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00566	CcSEcCtD
Oxazepam—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00566	CcSEcCtD
Oxazepam—Oedema—Dactinomycin—uterine cancer	0.00118	0.00558	CcSEcCtD
Oxazepam—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00527	CcSEcCtD
Oxazepam—Hepatic function abnormal—Epirubicin—uterine cancer	0.00111	0.00527	CcSEcCtD
Oxazepam—Dizziness—Progesterone—uterine cancer	0.0011	0.00522	CcSEcCtD
Oxazepam—Rash—Progesterone—uterine cancer	0.00105	0.00498	CcSEcCtD
Oxazepam—Dermatitis—Progesterone—uterine cancer	0.00105	0.00497	CcSEcCtD
Oxazepam—Headache—Progesterone—uterine cancer	0.00104	0.00495	CcSEcCtD
Oxazepam—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00103	0.00488	CcSEcCtD
Oxazepam—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000998	0.00473	CcSEcCtD
Oxazepam—Lethargy—Epirubicin—uterine cancer	0.000991	0.0047	CcSEcCtD
Oxazepam—Nausea—Progesterone—uterine cancer	0.000989	0.00469	CcSEcCtD
Oxazepam—UGT2B7—renal system—uterine cancer	0.000986	0.053	CbGeAlD
Oxazepam—Diplopia—Epirubicin—uterine cancer	0.000972	0.00461	CcSEcCtD
Oxazepam—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000962	0.00456	CcSEcCtD
Oxazepam—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000951	0.00451	CcSEcCtD
Oxazepam—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000951	0.00451	CcSEcCtD
Oxazepam—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000945	0.00448	CcSEcCtD
Oxazepam—Vertigo—Etoposide—uterine cancer	0.000938	0.00445	CcSEcCtD
Oxazepam—Leukopenia—Etoposide—uterine cancer	0.000934	0.00443	CcSEcCtD
Oxazepam—Abdominal pain—Dactinomycin—uterine cancer	0.00093	0.00441	CcSEcCtD
Oxazepam—Body temperature increased—Dactinomycin—uterine cancer	0.00093	0.00441	CcSEcCtD
Oxazepam—Loss of consciousness—Etoposide—uterine cancer	0.000917	0.00435	CcSEcCtD
Oxazepam—Lethargy—Doxorubicin—uterine cancer	0.000917	0.00435	CcSEcCtD
Oxazepam—Ataxia—Epirubicin—uterine cancer	0.000914	0.00433	CcSEcCtD
Oxazepam—Diplopia—Doxorubicin—uterine cancer	0.000899	0.00426	CcSEcCtD
Oxazepam—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000896	0.00425	CcSEcCtD
Oxazepam—GABRP—uterine cervix—uterine cancer	0.000867	0.0466	CbGeAlD
Oxazepam—Hypersensitivity—Dactinomycin—uterine cancer	0.000867	0.00411	CcSEcCtD
Oxazepam—GABRE—myometrium—uterine cancer	0.000851	0.0457	CbGeAlD
Oxazepam—Ataxia—Doxorubicin—uterine cancer	0.000845	0.00401	CcSEcCtD
Oxazepam—GABRP—decidua—uterine cancer	0.000826	0.0444	CbGeAlD
Oxazepam—Hypotension—Etoposide—uterine cancer	0.000796	0.00377	CcSEcCtD
Oxazepam—UGT2B7—female reproductive system—uterine cancer	0.00079	0.0424	CbGeAlD
Oxazepam—GABRP—endometrium—uterine cancer	0.000784	0.0422	CbGeAlD
Oxazepam—Paraesthesia—Etoposide—uterine cancer	0.000765	0.00363	CcSEcCtD
Oxazepam—GABRA4—mammalian vulva—uterine cancer	0.000764	0.0411	CbGeAlD
Oxazepam—Somnolence—Etoposide—uterine cancer	0.000757	0.00359	CcSEcCtD
Oxazepam—Drowsiness—Epirubicin—uterine cancer	0.000749	0.00355	CcSEcCtD
Oxazepam—Rash—Dactinomycin—uterine cancer	0.000742	0.00352	CcSEcCtD
Oxazepam—Jaundice—Epirubicin—uterine cancer	0.00073	0.00346	CcSEcCtD
Oxazepam—GABRP—uterus—uterine cancer	0.000723	0.0388	CbGeAlD
Oxazepam—Nausea—Dactinomycin—uterine cancer	0.000699	0.00332	CcSEcCtD
Oxazepam—Agranulocytosis—Epirubicin—uterine cancer	0.000699	0.00331	CcSEcCtD
Oxazepam—Gastrointestinal pain—Etoposide—uterine cancer	0.000697	0.0033	CcSEcCtD
Oxazepam—Drowsiness—Doxorubicin—uterine cancer	0.000693	0.00329	CcSEcCtD
Oxazepam—Jaundice—Doxorubicin—uterine cancer	0.000675	0.0032	CcSEcCtD
Oxazepam—Abdominal pain—Etoposide—uterine cancer	0.000673	0.00319	CcSEcCtD
Oxazepam—Body temperature increased—Etoposide—uterine cancer	0.000673	0.00319	CcSEcCtD
Oxazepam—GABRE—uterine cervix—uterine cancer	0.000662	0.0356	CbGeAlD
Oxazepam—GABRB1—vagina—uterine cancer	0.000656	0.0353	CbGeAlD
Oxazepam—GABRP—female reproductive system—uterine cancer	0.00065	0.0349	CbGeAlD
Oxazepam—Agranulocytosis—Doxorubicin—uterine cancer	0.000646	0.00307	CcSEcCtD
Oxazepam—GABRE—decidua—uterine cancer	0.000631	0.0339	CbGeAlD
Oxazepam—Hypersensitivity—Etoposide—uterine cancer	0.000628	0.00298	CcSEcCtD
Oxazepam—GABRE—endometrium—uterine cancer	0.000599	0.0322	CbGeAlD
Oxazepam—GABRP—vagina—uterine cancer	0.000588	0.0316	CbGeAlD
Oxazepam—GABRE—mammalian vulva—uterine cancer	0.000579	0.0311	CbGeAlD
Oxazepam—Dizziness—Etoposide—uterine cancer	0.000563	0.00267	CcSEcCtD
Oxazepam—Vision blurred—Epirubicin—uterine cancer	0.000551	0.00261	CcSEcCtD
Oxazepam—GABRR2—lymph node—uterine cancer	0.000543	0.0292	CbGeAlD
Oxazepam—Agitation—Epirubicin—uterine cancer	0.000538	0.00255	CcSEcCtD
Oxazepam—Rash—Etoposide—uterine cancer	0.000537	0.00255	CcSEcCtD
Oxazepam—Dermatitis—Etoposide—uterine cancer	0.000537	0.00254	CcSEcCtD
Oxazepam—Headache—Etoposide—uterine cancer	0.000534	0.00253	CcSEcCtD
Oxazepam—Vertigo—Epirubicin—uterine cancer	0.000526	0.00249	CcSEcCtD
Oxazepam—Syncope—Epirubicin—uterine cancer	0.000525	0.00249	CcSEcCtD
Oxazepam—Leukopenia—Epirubicin—uterine cancer	0.000524	0.00248	CcSEcCtD
Oxazepam—Loss of consciousness—Epirubicin—uterine cancer	0.000514	0.00244	CcSEcCtD
Oxazepam—Vision blurred—Doxorubicin—uterine cancer	0.00051	0.00242	CcSEcCtD
Oxazepam—Nausea—Etoposide—uterine cancer	0.000506	0.0024	CcSEcCtD
Oxazepam—Agitation—Doxorubicin—uterine cancer	0.000497	0.00236	CcSEcCtD
Oxazepam—GABRE—female reproductive system—uterine cancer	0.000496	0.0267	CbGeAlD
Oxazepam—Vertigo—Doxorubicin—uterine cancer	0.000486	0.00231	CcSEcCtD
Oxazepam—Syncope—Doxorubicin—uterine cancer	0.000485	0.0023	CcSEcCtD
Oxazepam—Leukopenia—Doxorubicin—uterine cancer	0.000485	0.0023	CcSEcCtD
Oxazepam—Oedema—Epirubicin—uterine cancer	0.000478	0.00226	CcSEcCtD
Oxazepam—Loss of consciousness—Doxorubicin—uterine cancer	0.000476	0.00226	CcSEcCtD
Oxazepam—Shock—Epirubicin—uterine cancer	0.00047	0.00223	CcSEcCtD
Oxazepam—GABRA2—vagina—uterine cancer	0.000452	0.0243	CbGeAlD
Oxazepam—GABRE—female gonad—uterine cancer	0.000451	0.0243	CbGeAlD
Oxazepam—GABRE—vagina—uterine cancer	0.000449	0.0241	CbGeAlD
Oxazepam—Hypotension—Epirubicin—uterine cancer	0.000446	0.00212	CcSEcCtD
Oxazepam—Oedema—Doxorubicin—uterine cancer	0.000442	0.0021	CcSEcCtD
Oxazepam—Shock—Doxorubicin—uterine cancer	0.000435	0.00206	CcSEcCtD
Oxazepam—Paraesthesia—Epirubicin—uterine cancer	0.000429	0.00203	CcSEcCtD
Oxazepam—Somnolence—Epirubicin—uterine cancer	0.000424	0.00201	CcSEcCtD
Oxazepam—GABRB3—female reproductive system—uterine cancer	0.00042	0.0226	CbGeAlD
Oxazepam—Hypotension—Doxorubicin—uterine cancer	0.000413	0.00196	CcSEcCtD
Oxazepam—Paraesthesia—Doxorubicin—uterine cancer	0.000397	0.00188	CcSEcCtD
Oxazepam—Somnolence—Doxorubicin—uterine cancer	0.000393	0.00186	CcSEcCtD
Oxazepam—Gastrointestinal pain—Epirubicin—uterine cancer	0.00039	0.00185	CcSEcCtD
Oxazepam—CYP3A5—uterine cervix—uterine cancer	0.000383	0.0206	CbGeAlD
Oxazepam—Body temperature increased—Epirubicin—uterine cancer	0.000377	0.00179	CcSEcCtD
Oxazepam—Abdominal pain—Epirubicin—uterine cancer	0.000377	0.00179	CcSEcCtD
Oxazepam—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000361	0.00171	CcSEcCtD
Oxazepam—CYP3A5—renal system—uterine cancer	0.000358	0.0192	CbGeAlD
Oxazepam—Hypersensitivity—Epirubicin—uterine cancer	0.000352	0.00167	CcSEcCtD
Oxazepam—Abdominal pain—Doxorubicin—uterine cancer	0.000349	0.00166	CcSEcCtD
Oxazepam—Body temperature increased—Doxorubicin—uterine cancer	0.000349	0.00166	CcSEcCtD
Oxazepam—Hypersensitivity—Doxorubicin—uterine cancer	0.000326	0.00154	CcSEcCtD
Oxazepam—Dizziness—Epirubicin—uterine cancer	0.000316	0.0015	CcSEcCtD
Oxazepam—Rash—Epirubicin—uterine cancer	0.000301	0.00143	CcSEcCtD
Oxazepam—Dermatitis—Epirubicin—uterine cancer	0.000301	0.00143	CcSEcCtD
Oxazepam—Headache—Epirubicin—uterine cancer	0.000299	0.00142	CcSEcCtD
Oxazepam—GABRA2—lymph node—uterine cancer	0.000293	0.0157	CbGeAlD
Oxazepam—Dizziness—Doxorubicin—uterine cancer	0.000292	0.00139	CcSEcCtD
Oxazepam—GABRE—lymph node—uterine cancer	0.00029	0.0156	CbGeAlD
Oxazepam—Nausea—Epirubicin—uterine cancer	0.000284	0.00135	CcSEcCtD
Oxazepam—Rash—Doxorubicin—uterine cancer	0.000279	0.00132	CcSEcCtD
Oxazepam—Dermatitis—Doxorubicin—uterine cancer	0.000278	0.00132	CcSEcCtD
Oxazepam—Headache—Doxorubicin—uterine cancer	0.000277	0.00131	CcSEcCtD
Oxazepam—CYP3A4—renal system—uterine cancer	0.000269	0.0144	CbGeAlD
Oxazepam—Nausea—Doxorubicin—uterine cancer	0.000262	0.00124	CcSEcCtD
Oxazepam—CYP3A5—female gonad—uterine cancer	0.000261	0.014	CbGeAlD
Oxazepam—CYP3A5—vagina—uterine cancer	0.000259	0.0139	CbGeAlD
Oxazepam—CYP3A4—female reproductive system—uterine cancer	0.000215	0.0116	CbGeAlD
Oxazepam—UGT2B7—Metapathway biotransformation—CYP11A1—uterine cancer	1.3e-05	0.00588	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—AKR1C1—uterine cancer	1.3e-05	0.00587	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—ABCC9—uterine cancer	1.3e-05	0.00586	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—ABCC9—uterine cancer	1.27e-05	0.00576	CbGpPWpGaD
Oxazepam—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.25e-05	0.00565	CbGpPWpGaD
Oxazepam—UGT2B7—Metapathway biotransformation—AKR1C3—uterine cancer	1.23e-05	0.00556	CbGpPWpGaD
Oxazepam—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	1.23e-05	0.00555	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—AKR1B10—uterine cancer	1.15e-05	0.00523	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—SRD5A2—uterine cancer	1.14e-05	0.00518	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—NDUFB11—uterine cancer	1.14e-05	0.00518	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—GPX3—uterine cancer	1.14e-05	0.00515	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.13e-05	0.00512	CbGpPWpGaD
Oxazepam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.11e-05	0.00504	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—ABCC9—uterine cancer	1.11e-05	0.00503	CbGpPWpGaD
Oxazepam—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.1e-05	0.00497	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—AKR1C1—uterine cancer	1.09e-05	0.00493	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.08e-05	0.00488	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.08e-05	0.00488	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—AKR1B1—uterine cancer	1.07e-05	0.00486	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—CYP11A1—uterine cancer	1.07e-05	0.00485	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—CYP11A1—uterine cancer	1.06e-05	0.00478	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	1.03e-05	0.00465	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—AKR1C3—uterine cancer	9.98e-06	0.00452	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—CYP19A1—uterine cancer	9.7e-06	0.00439	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—GPX3—uterine cancer	9.57e-06	0.00433	CbGpPWpGaD
Oxazepam—UGT2B7—Metapathway biotransformation—CYP19A1—uterine cancer	9.57e-06	0.00433	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.51e-06	0.0043	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	9.3e-06	0.00421	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	9.02e-06	0.00408	CbGpPWpGaD
Oxazepam—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	9.02e-06	0.00408	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—CYP11A1—uterine cancer	9.01e-06	0.00408	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—CYP11A1—uterine cancer	8.88e-06	0.00402	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.88e-06	0.00402	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—SRD5A2—uterine cancer	8.84e-06	0.004	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—NDUFB11—uterine cancer	8.84e-06	0.004	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.75e-06	0.00396	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—ESR2—uterine cancer	8.58e-06	0.00388	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—AKR1C3—uterine cancer	8.39e-06	0.0038	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.28e-06	0.00375	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—AKR1B1—uterine cancer	8.27e-06	0.00374	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—STAR—uterine cancer	8.27e-06	0.00374	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.18e-06	0.0037	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—CYP19A1—uterine cancer	7.88e-06	0.00357	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—AKR1C1—uterine cancer	7.88e-06	0.00357	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—CYP19A1—uterine cancer	7.77e-06	0.00352	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.48e-06	0.00338	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.27e-06	0.00329	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.13e-06	0.00323	CbGpPWpGaD
Oxazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	7.03e-06	0.00318	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.01e-06	0.00317	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.97e-06	0.00315	CbGpPWpGaD
Oxazepam—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	6.94e-06	0.00314	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—GPX3—uterine cancer	6.92e-06	0.00313	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.87e-06	0.00311	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.87e-06	0.00311	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.84e-06	0.0031	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—CYP19A1—uterine cancer	6.63e-06	0.003	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—CYP19A1—uterine cancer	6.54e-06	0.00296	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	6.51e-06	0.00295	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—POLD1—uterine cancer	6.49e-06	0.00294	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	6.42e-06	0.00291	CbGpPWpGaD
Oxazepam—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	6.4e-06	0.0029	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—STAR—uterine cancer	6.39e-06	0.00289	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—AKR1B1—uterine cancer	6.39e-06	0.00289	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—AKR1C1—uterine cancer	6.07e-06	0.00275	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	6.07e-06	0.00275	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.98e-06	0.00271	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	5.7e-06	0.00258	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—RRM2—uterine cancer	5.41e-06	0.00245	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	5.37e-06	0.00243	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—DCN—uterine cancer	5.25e-06	0.00238	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—SRD5A2—uterine cancer	5.21e-06	0.00236	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—NDUFB11—uterine cancer	5.21e-06	0.00236	CbGpPWpGaD
Oxazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	5.17e-06	0.00234	CbGpPWpGaD
Oxazepam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.1e-06	0.00231	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.05e-06	0.00228	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—POLD1—uterine cancer	5.02e-06	0.00227	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	4.99e-06	0.00226	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CYP11A1—uterine cancer	4.95e-06	0.00224	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	4.79e-06	0.00217	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	4.73e-06	0.00214	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—AKR1C1—uterine cancer	4.69e-06	0.00212	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—AKR1C3—uterine cancer	4.67e-06	0.00212	CbGpPWpGaD
Oxazepam—UGT1A9—PPARA activates gene expression—EP300—uterine cancer	4.49e-06	0.00203	CbGpPWpGaD
Oxazepam—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	4.4e-06	0.00199	CbGpPWpGaD
Oxazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	4.39e-06	0.00199	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—NDUFB11—uterine cancer	4.23e-06	0.00192	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—SRD5A2—uterine cancer	4.23e-06	0.00192	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.19e-06	0.0019	CbGpPWpGaD
Oxazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	4.18e-06	0.00189	CbGpPWpGaD
Oxazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	4.18e-06	0.00189	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—RRM2—uterine cancer	4.18e-06	0.00189	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—CTNNB1—uterine cancer	4.15e-06	0.00188	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.11e-06	0.00186	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—DCN—uterine cancer	4.06e-06	0.00184	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.88e-06	0.00176	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CYP11A1—uterine cancer	3.82e-06	0.00173	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—STAR—uterine cancer	3.77e-06	0.00171	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—AKR1B1—uterine cancer	3.77e-06	0.00171	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.66e-06	0.00166	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—STK11—uterine cancer	3.64e-06	0.00165	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CYP19A1—uterine cancer	3.64e-06	0.00165	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	3.62e-06	0.00164	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—AKR1C3—uterine cancer	3.61e-06	0.00163	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—SRD5A2—uterine cancer	3.56e-06	0.00161	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—NDUFB11—uterine cancer	3.56e-06	0.00161	CbGpPWpGaD
Oxazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	3.45e-06	0.00156	CbGpPWpGaD
Oxazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	3.39e-06	0.00154	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	3.34e-06	0.00151	CbGpPWpGaD
Oxazepam—GABRR1—Transmission across Chemical Synapses—HRAS—uterine cancer	3.3e-06	0.00149	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.22e-06	0.00146	CbGpPWpGaD
Oxazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	3.21e-06	0.00145	CbGpPWpGaD
Oxazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	3.17e-06	0.00144	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—HRAS—uterine cancer	3.15e-06	0.00142	CbGpPWpGaD
Oxazepam—GABRQ—Transmission across Chemical Synapses—HRAS—uterine cancer	3.15e-06	0.00142	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—EP300—uterine cancer	3.11e-06	0.00141	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—AKR1B1—uterine cancer	3.06e-06	0.00139	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—STAR—uterine cancer	3.06e-06	0.00139	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	3.03e-06	0.00137	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.03e-06	0.00137	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.03e-06	0.00137	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.99e-06	0.00135	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—POLD1—uterine cancer	2.96e-06	0.00134	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	2.94e-06	0.00133	CbGpPWpGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.9e-06	0.00131	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.82e-06	0.00128	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.82e-06	0.00128	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—STK11—uterine cancer	2.81e-06	0.00127	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CYP19A1—uterine cancer	2.81e-06	0.00127	CbGpPWpGaD
Oxazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.77e-06	0.00125	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—AKR1C1—uterine cancer	2.77e-06	0.00125	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—MTHFR—uterine cancer	2.74e-06	0.00124	CbGpPWpGaD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.72e-06	0.00123	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.7e-06	0.00122	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.65e-06	0.0012	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—HRAS—uterine cancer	2.64e-06	0.0012	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—HRAS—uterine cancer	2.59e-06	0.00117	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—AKR1B1—uterine cancer	2.57e-06	0.00117	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—STAR—uterine cancer	2.57e-06	0.00117	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—NDUFB11—uterine cancer	2.57e-06	0.00117	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—SRD5A2—uterine cancer	2.57e-06	0.00117	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—HRAS—uterine cancer	2.55e-06	0.00115	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—HRAS—uterine cancer	2.53e-06	0.00114	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—RRM2—uterine cancer	2.46e-06	0.00112	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—HRAS—uterine cancer	2.41e-06	0.00109	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—HRAS—uterine cancer	2.41e-06	0.00109	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—HRAS—uterine cancer	2.41e-06	0.00109	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—POLD1—uterine cancer	2.4e-06	0.00109	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—DCN—uterine cancer	2.39e-06	0.00108	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—HRAS—uterine cancer	2.38e-06	0.00108	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—AKT1—uterine cancer	2.33e-06	0.00106	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.32e-06	0.00105	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYP11A1—uterine cancer	2.25e-06	0.00102	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—AKR1C1—uterine cancer	2.25e-06	0.00102	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.23e-06	0.00101	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.2e-06	0.000994	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—HRAS—uterine cancer	2.18e-06	0.000987	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—AKR1C3—uterine cancer	2.13e-06	0.000964	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—HRAS—uterine cancer	2.12e-06	0.000959	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—MTHFR—uterine cancer	2.11e-06	0.000957	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—HRAS—uterine cancer	2.08e-06	0.000942	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—HRAS—uterine cancer	2.04e-06	0.000925	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—HRAS—uterine cancer	2.03e-06	0.000919	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—POLD1—uterine cancer	2.02e-06	0.000915	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—RRM2—uterine cancer	2e-06	0.000907	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—HRAS—uterine cancer	1.99e-06	0.000903	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—HRAS—uterine cancer	1.98e-06	0.000898	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—HRAS—uterine cancer	1.96e-06	0.000885	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—DCN—uterine cancer	1.94e-06	0.00088	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—AKR1C1—uterine cancer	1.89e-06	0.000855	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—AKR1B1—uterine cancer	1.86e-06	0.000842	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—STAR—uterine cancer	1.86e-06	0.000842	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—HRAS—uterine cancer	1.85e-06	0.000837	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYP11A1—uterine cancer	1.83e-06	0.000829	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—HRAS—uterine cancer	1.83e-06	0.000827	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—HRAS—uterine cancer	1.74e-06	0.000789	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—AKR1C3—uterine cancer	1.73e-06	0.000783	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—RRM2—uterine cancer	1.68e-06	0.000762	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—HRAS—uterine cancer	1.67e-06	0.000756	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—STK11—uterine cancer	1.66e-06	0.000751	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYP19A1—uterine cancer	1.66e-06	0.000751	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—DCN—uterine cancer	1.64e-06	0.00074	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—HRAS—uterine cancer	1.62e-06	0.000735	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—HRAS—uterine cancer	1.59e-06	0.000721	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—HRAS—uterine cancer	1.57e-06	0.000709	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—HRAS—uterine cancer	1.56e-06	0.000704	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYP11A1—uterine cancer	1.54e-06	0.000697	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—HRAS—uterine cancer	1.53e-06	0.000692	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PTEN—uterine cancer	1.52e-06	0.000689	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—POLD1—uterine cancer	1.46e-06	0.000661	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—AKR1C3—uterine cancer	1.45e-06	0.000659	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—EP300—uterine cancer	1.45e-06	0.000657	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.37e-06	0.000618	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYP19A1—uterine cancer	1.35e-06	0.00061	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—STK11—uterine cancer	1.35e-06	0.00061	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—HRAS—uterine cancer	1.34e-06	0.000605	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.27e-06	0.000573	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—MTHFR—uterine cancer	1.25e-06	0.000564	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—RRM2—uterine cancer	1.22e-06	0.000551	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.21e-06	0.000546	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.2e-06	0.000542	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.2e-06	0.000542	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—DCN—uterine cancer	1.18e-06	0.000535	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PTEN—uterine cancer	1.18e-06	0.000532	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—STK11—uterine cancer	1.13e-06	0.000513	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYP19A1—uterine cancer	1.13e-06	0.000513	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—EP300—uterine cancer	1.12e-06	0.000508	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.11e-06	0.000504	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PIK3CA—uterine cancer	1.07e-06	0.000486	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.05e-06	0.000476	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—MTHFR—uterine cancer	1.01e-06	0.000458	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.92e-07	0.000404	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—AKT1—uterine cancer	8.77e-07	0.000397	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—STAR—uterine cancer	8.65e-07	0.000392	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—AKR1B1—uterine cancer	8.65e-07	0.000392	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—MTHFR—uterine cancer	8.52e-07	0.000386	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PIK3CA—uterine cancer	8.3e-07	0.000376	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—STK11—uterine cancer	8.19e-07	0.000371	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYP19A1—uterine cancer	8.19e-07	0.000371	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PTEN—uterine cancer	6.93e-07	0.000314	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—POLD1—uterine cancer	6.79e-07	0.000307	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—AKT1—uterine cancer	6.78e-07	0.000307	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—EP300—uterine cancer	6.61e-07	0.000299	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—AKR1C1—uterine cancer	6.35e-07	0.000287	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—MTHFR—uterine cancer	6.16e-07	0.000279	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—RRM2—uterine cancer	5.66e-07	0.000256	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PTEN—uterine cancer	5.63e-07	0.000255	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—DCN—uterine cancer	5.5e-07	0.000249	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—EP300—uterine cancer	5.37e-07	0.000243	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYP11A1—uterine cancer	5.18e-07	0.000234	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PIK3CA—uterine cancer	4.89e-07	0.000221	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.89e-07	0.000221	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PTEN—uterine cancer	4.74e-07	0.000214	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—EP300—uterine cancer	4.52e-07	0.000205	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—AKT1—uterine cancer	4e-07	0.000181	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PIK3CA—uterine cancer	3.97e-07	0.00018	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.81e-07	0.000172	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—STK11—uterine cancer	3.81e-07	0.000172	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PTEN—uterine cancer	3.43e-07	0.000155	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PIK3CA—uterine cancer	3.34e-07	0.000151	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—EP300—uterine cancer	3.27e-07	0.000148	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—AKT1—uterine cancer	3.25e-07	0.000147	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—MTHFR—uterine cancer	2.86e-07	0.00013	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—AKT1—uterine cancer	2.73e-07	0.000124	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.42e-07	0.000109	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—AKT1—uterine cancer	1.97e-07	8.93e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PTEN—uterine cancer	1.59e-07	7.21e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—EP300—uterine cancer	1.52e-07	6.87e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.12e-07	5.08e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—AKT1—uterine cancer	9.18e-08	4.15e-05	CbGpPWpGaD
